Literature DB >> 31619588

MicroRNA-7a overexpression in VMH restores the sympathoadrenal response to hypoglycemia.

Rahul Agrawal1, Griffin Durupt1, Dinesh Verma2, Michael Montgomery1, Adriana Vieira-de Abreu1, Casey Taylor1, Sankar Swaminathan2, Simon J Fisher1,3.   

Abstract

It is proposed that the impaired sympathoadrenal response to hypoglycemia induced by recurrent insulin-induced hypoglycemia (RH) is an adaptive phenomenon induced by specific changes in microRNA expression in the ventromedial hypothalamus (VMH). To test this hypothesis, genome-wide microRNAomic profiling of the VMH by RNA-sequencing was performed in control rats and rats treated for RH. Differential expression analysis identified microRNA-7a-5p and microRNA-665 as potential mediators of this phenomenon. To further test this hypothesis, experiments were conducted consisting of targeted lentiviral-mediated overexpression of microRNA-7a-5p and downregulation of microRNA-665 in the VMH. Hyperinsulinemic hypoglycemic clamp experiments demonstrated that targeted overexpression of microRNA-7a-5p (but not downregulation of microRNA-665) in the VMH of RH rats restored the epinephrine response to hypoglycemia. This restored response to hypoglycemia was associated with a restoration of GABAA receptor gene expression. Finally, a direct interaction of microRNA-7a-5p with the 3'-UTR of GABAA receptor α1-subunit (Gabra1) gene was demonstrated in a luciferase assay. These findings indicate that (a) the impaired sympathoadrenal response RH induces is associated with changes in VMH microRNA expression and (b) microRNA-7a-5p, possibly via direct downregulation of GABA receptor gene expression, may serve as a mediator of the altered sympathoadrenal response to hypoglycemia.

Entities:  

Keywords:  Endocrinology; Noncoding RNAs

Year:  2019        PMID: 31619588      PMCID: PMC6824313          DOI: 10.1172/jci.insight.130521

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  38 in total

Review 1.  MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship.

Authors:  Amy E Pasquinelli
Journal:  Nat Rev Genet       Date:  2012-03-13       Impact factor: 53.242

2.  Locked nucleic acid-based in situ hybridisation reveals miR-7a as a hypothalamus-enriched microRNA with a distinct expression pattern.

Authors:  S Herzer; A Silahtaroglu; B Meister
Journal:  J Neuroendocrinol       Date:  2012-12       Impact factor: 3.627

3.  Characterization of human thioredoxin-like-1: potential involvement in the cellular response against glucose deprivation.

Authors:  Alberto Jiménez; Markku Pelto-Huikko; Jan-Ake Gustafsson; Antonio Miranda-Vizuete
Journal:  FEBS Lett       Date:  2006-01-19       Impact factor: 4.124

4.  Acute induction of gene expression in brain and liver by insulin-induced hypoglycemia.

Authors:  Jason W Mastaitis; Elisa Wurmbach; Hui Cheng; Stuart C Sealfon; Charles V Mobbs
Journal:  Diabetes       Date:  2005-04       Impact factor: 9.461

5.  Blockade of GABA(A) receptors in the ventromedial hypothalamus further stimulates glucagon and sympathoadrenal but not the hypothalamo-pituitary-adrenal response to hypoglycemia.

Authors:  Owen Chan; Wanling Zhu; Yuyan Ding; Rory J McCrimmon; Robert S Sherwin
Journal:  Diabetes       Date:  2006-04       Impact factor: 9.461

6.  A novel interaction between sympathetic overactivity and aberrant regulation of renin by miR-181a in BPH/2J genetically hypertensive mice.

Authors:  Kristy L Jackson; Francine Z Marques; Anna M D Watson; Kesia Palma-Rigo; Thu-Phuc Nguyen-Huu; Brian J Morris; Fadi J Charchar; Pamela J Davern; Geoffrey A Head
Journal:  Hypertension       Date:  2013-07-29       Impact factor: 10.190

7.  Testicular regulation of neuronal glucose and monocarboxylate transporter gene expression profiles in CNS metabolic sensing sites during acute and recurrent insulin-induced hypoglycemia.

Authors:  Kamlesh V Vavaiya; Sachin A Paranjape; Karen P Briski
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

8.  Recurrent moderate hypoglycemia ameliorates brain damage and cognitive dysfunction induced by severe hypoglycemia.

Authors:  Erwin C Puente; Julie Silverstein; Adam J Bree; Daniel R Musikantow; David F Wozniak; Susan Maloney; Dorit Daphna-Iken; Simon J Fisher
Journal:  Diabetes       Date:  2010-01-19       Impact factor: 9.461

9.  Postnatal β-cell maturation is associated with islet-specific microRNA changes induced by nutrient shifts at weaning.

Authors:  Cécile Jacovetti; Scot J Matkovich; Adriana Rodriguez-Trejo; Claudiane Guay; Romano Regazzi
Journal:  Nat Commun       Date:  2015-09-02       Impact factor: 14.919

Review 10.  Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128.

Authors:  Yogita K Adlakha; Neeru Saini
Journal:  Mol Cancer       Date:  2014-02-21       Impact factor: 27.401

View more
  3 in total

1.  Hypothalamic miR-1983 Targets Insulin Receptor β and the Insulin-mediated miR-1983 Increase Is Blocked by Metformin.

Authors:  Jennifer A Chalmers; Prasad S Dalvi; Neruja Loganathan; Emma K McIlwraith; Leigh Wellhauser; Anaies Nazarians-Armavil; Judith A Eversley; Haneesha Mohan; Priska Stahel; Satya Dash; Michael B Wheeler; Denise D Belsham
Journal:  Endocrinology       Date:  2022-01-01       Impact factor: 4.736

2.  Single-cell multiplex qPCR evidence for sex-dimorphic glutamate decarboxylase, estrogen receptor, and 5'-AMP-activated protein kinase alpha subunit mRNA expression by ventromedial hypothalamic nucleus GABAergic neurons.

Authors:  Md Haider Ali; Ayed A Alshamrani; Prabhat R Napit; Karen P Briski
Journal:  J Chem Neuroanat       Date:  2022-06-27       Impact factor: 3.097

3.  MiRNA and associated inflammatory changes from baseline to hypoglycemia in type 2 diabetes.

Authors:  Manjunath Ramanjaneya; Ruth Priyanka; Milin Bensila; Jayakumar Jerobin; Krunal Pawar; Thozhukat Sathyapalan; Abdul Badi Abou-Samra; Najeeb M Halabi; Abu Saleh Md Moin; Stephen L Atkin; Alexandra E Butler
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-09       Impact factor: 6.055

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.